Literature DB >> 27862791

Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis.

Hiroki Nishikawa1, Hirayuki Enomoto1, Akio Ishii1, Yoshinori Iwata1, Yuho Miyamoto1, Noriko Ishii1, Yukihisa Yuri1, Ryo Takata1, Kunihiro Hasegawa1, Chikage Nakano1, Takashi Nishimura1, Kazunori Yoh1, Nobuhiro Aizawa1, Yoshiyuki Sakai1, Naoto Ikeda1, Tomoyuki Takashima1, Hiroko Iijima1, Shuhei Nishiguchi1.   

Abstract

AIMS: To investigate the impact of low skeletal muscle mass (LSMM) on survival as compared with protein-energy malnutrition (PEM) in patients with liver cirrhosis (LC).
METHODS: A total of 206 individuals with LC were analyzed. We retrospectively examined the impact of LSMM, as defined by psoas muscle mass at the third lumber on computed tomography, on survival as compared with PEM. In terms of comparison of the effects of LSMM and PEM on survival, we used time-dependent receiver operating characteristics (ROC) analysis.
RESULTS: Our study cohort included 115 men and 91 women with a median age of 67 years. There were 140 patients with Child-Pugh A, 62 with Child-Pugh B, and 4 with Child-Pugh C. A total of 117 patients (56.8%) had LSMM and 52 patients (25.2%) had PEM. The proportion of PEM in patients with LSMM (31.62%, 37/117) was significantly higher than in patients without LSMM (16.85%, 15/89) (P = 0.0229). In the multivariate analysis for the entire cohort, the presence of hepatocellular carcinoma, lower body mass index, presence of LSMM, lower triglyceride value, poorer renal function, and higher des-γ-carboxy prothrombin value were found to be significant adverse predictors linked to overall survival, while presence of PEM tended to be significant. In the time-dependent ROC analysis, all area under the ROCs for survival in LSMM at each time point were higher than those in PEM except for Child-Pugh B patients.
CONCLUSION: In this comparison of LSMM and PEM on clinical outcomes in LC patients, it was shown that LSMM may have stronger prognostic impact than PEM.
© 2016 The Japan Society of Hepatology.

Entities:  

Keywords:  clinical outcomes; comparison; liver cirrhosis; low skeletal muscle mass; protein-energy malnutrition

Year:  2017        PMID: 27862791     DOI: 10.1111/hepr.12843

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 3.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

4.  Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Ann Transl Med       Date:  2021-04

5.  Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.

Authors:  Yoshiyuki Sakai; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.

Authors:  Yukihisa Yuri; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Cancer       Date:  2017-06-01       Impact factor: 4.207

Review 7.  Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives.

Authors:  Emanuele Rinninella; Lucia Cerrito; Irene Spinelli; Marco Cintoni; Maria Cristina Mele; Maurizio Pompili; Antonio Gasbarrini
Journal:  J Clin Transl Hepatol       Date:  2017-06-08

Review 8.  Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

9.  Systematic review and meta-analysis of lean mass and mortality: Rationale and study description.

Authors:  Ching-Lung Cheung; Grace Koon-Yee Lee; Philip Chun-Ming Au; Gloria Hoi-Yee Li; Marcus Chan; Hang-Long Li; Bernard Man-Yung Cheung; Ian Chi-Kei Wong; Victor Ho-Fun Lee; James Mok; Benjamin Hon-Kei Yip; Kenneth King-Yip Cheng; Chih-Hsing Wu
Journal:  Osteoporos Sarcopenia       Date:  2021-02-11

10.  Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease.

Authors:  Nicholas C Wang; Peng Zhang; Elliot B Tapper; Sameer Saini; Stewart C Wang; Grace L Su
Journal:  Am J Gastroenterol       Date:  2020-08       Impact factor: 12.045

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.